Hepatic resection for metastatic melanoma in The Netherlands: Survival and prognostic factors

Melanoma Research

Volumn 23, Issue 1, 2013, Pages 27-32

  De Ridder, Jannemarie ^a   Van Walsum, Marlies ^b   Verhoef, Cornelis ^c   Nagtegaal, Iris ^a   De Wilt, Johannes ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CPRLab   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Hepatic resection; Metastases; Metastatic melanoma

Indexed keywords

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CYTOPATHOLOGY; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; FEMALE; HEMATOMA; HEMIHEPATECTOMY; HISTOPATHOLOGY; HUMAN; ILEUS; ISOLATED LIVER; LAPAROTOMY; LIVER BIOPSY; LIVER FAILURE; LIVER METASTASIS; LIVER RESECTION; MALE; METASTATIC MELANOMA; NETHERLANDS; OVERALL SURVIVAL; PERCUTANEOUS DRAINAGE; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; PRIORITY JOURNAL; SURGICAL MORTALITY;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 84872073662     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32835b70c8     Document Type: Article

References (46)

1. Reintgen DS, Cox C, Slingluff CL Jr, Seigler HF. Recurrent malignant melanoma: The identification of prognostic factors to predict survival. Ann Plast Surg 1992; 28:45-49
2. Soong SJ, Harrison RA, McCarthy WH, Urist MM, Balch CM. Factors affecting survival following local, regional, or distant recurrence from localized melanoma. J Surg Oncol 1998; 67:228-233 (Pubitemid 28196912)
3. Leiter U, Meier F, Schittek B, Garbe C. The natural course of cutaneous melanoma. J Surg Oncol 2004; 86:172-178 (Pubitemid 38880283)
4. Gragoudas ES, Egan KM, Seddon JM, Glynn RJ,Walsh SM, Finn SM, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology 1991; 98:383-389, discussion 390
5. Balch CM, Soong SJ, Murad TM, Smith JW, Maddox WA, Durant JR, et al. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol 1983; 1:126-134 (Pubitemid 14176801)
6. Barth A, Wanek LA, Morton DL. Prognostic factors in 1521 melanoma patients with distant metastases. J Am Coll Surg 1995; 181:193-201
7. Hauschild A, Grob JJ, Demidov LV, Jouary T, Gutzmer R, Millward M, et al. Dabrafenib in BRAF-mutated metastatic melanoma: A multicentre, openlabel, phase 3 randomised controlled trial. Lancet 2012; 380:358-365
8. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363:711-723
9. O'Day SJ, Kim CJ, Reintgen DS. Metastatic melanoma: Chemotherapy to biochemotherapy. Cancer Control 2002; 9:31-38 (Pubitemid 34203257)
10. House MG, Ito H, Gönen M, Fong Y, Allen PJ, DeMatteo RP, et al. Survival after hepatic resection for metastatic colorectal cancer: Trends in outcomes for 1600 patients during two decades at a single institution. J Am Coll Surg 2010; 210:744-752, 752-755
11. Morris EJ, Forman D, Thomas JD, Quirke P, Taylor EF, Fairley L, et al. Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 2010; 97:1110-1118
12. Smith MD, McCall JL. Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases. Br J Surg 2009; 96:1101-1113
13. Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, et al. Pathology databanking and biobanking in the Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 2007; 29:19-24 (Pubitemid 46535194)
14. Earle SA, Perez EA, Gutierrez JC, Sleeman D, Livingstone AS, Franceschi D, et al. Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis. J Am Coll Surg 2006; 203:436-446 (Pubitemid 44416263)
15. Goering JD, Mahvi DM, Niederhuber JE, Chicks D, Rikkers LF. Cryoablation and liver resection for noncolorectal liver metastases. Am J Surg 2002; 183:384-389 (Pubitemid 34442502)
16. Goere D, Elias D. Resection of liver metastases from non-colorectal nonendocrine primary tumours. Eur J Surg Oncol 2008; 34:281-288 (Pubitemid 351312862)
17. Schmelzle M, Eisenberger CF, am Esch JS II, Matthaei H, Krausch M, Knoefel WT. Non-colorectal, non-neuroendocrine, and non-sarcoma metastases of the liver: Resection as a promising tool in the palliative management. Langenbecks Arch Surg 2010; 395:227-234
18. O'Rourke TR, Tekkis P, Yeung S, Fawcett J, Lynch S, Strong R, et al. Longterm results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann Surg Oncol 2008; 15:207-218
19. Van Ruth S, Mutsaerts E, Zoetmulder FA, van Coevorden F. Metastasectomy for liver metastases of non-colorectal primaries. Eur J Surg Oncol 2001; 27:662-667 (Pubitemid 33062174)
20. Weitz J, Blumgart LH, Fong Y, Jarnagin WR, D'Angelica M, Harrison LE, et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg 2005; 241:269-276
21. Rose DM, Essner R, Hughes TM, Tang PC, Bilchik A,Wanek LA. Surgical resection for metastatic melanoma to the liver: The JohnWayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg 2001; 136:950-955 (Pubitemid 32729559)
22. Karavias DD, Tepetes K, Karatzas T, Felekouras E, Androulakis J. Liver resection for metastatic non-colorectal non-neuroendocrine hepatic neoplasms. Eur J Surg Oncol 2002; 28:135-139 (Pubitemid 35023654)
23. Adam R, Chiche L, Aloia T, Elias D, Salmon R, Rivoire M, et al. Hepatic resection for noncolorectal nonendocrine liver metastases: Analysis of 1452 patients and development of a prognostic model. Ann Surg 2006; 244:524-535
24. Frenkel S, Nir I, Hendler K, Lotem M, Eid A, Jurim O, Pe'er J. Long-term survival of uveal melanoma patients after surgery for liver metastases. Br J Ophthalmol 2009; 93:1042-1046
25. Pawlik TM, Zorzi D, Abdalla EK, Clary BM, Gershenwald JE, Ross MI, et al. Hepatic resection for metastatic melanoma: Distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol 2006; 13:712-720
26. Laurent C, Rullier E, Feyler A, Masson B, Saric J. Resection of noncolorectal and nonneuroendocrine liver metastases: Late metastases are the only chance of cure. World J Surg 2001; 25:1532-1536 (Pubitemid 34028388)
27. Harrison LE, Brennan MF, Newman E, Fortner JG, Picardo A, Blumgart LH, et al. Hepatic resection for noncolorectal, nonneuroendocrine metastases: A fifteen-year experience with ninety-six patients. Surgery 1997; 121:625-632 (Pubitemid 27251901)
28. Hemming AW, Sielaff TD, Gallinger S, Cattral MS, Taylor BR, Greig PD, et al. Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl 2000; 6:97-101 (Pubitemid 30123375)
29. Berney T, Mentha G, Roth AD, Morel P. Results of surgical resection of liver metastases from non-colorectal primaries. Br J Surg 1998; 85:1423-1427 (Pubitemid 28468352)
30. Lindell G, Ohlsson B, Saarela A, Andersson R, Tranberg KG. Liver resection of noncolorectal secondaries. J Surg Oncol 1998; 69:66-70 (Pubitemid 28515962)
31. Ercolani G, Grazi GL, Ravaioli M, Ramacciato G, Cescon M, Varotti G, et al. The role of liver resections for noncolorectal, nonneuroendocrine metastases: Experience with 142 observed cases. Ann Surg Oncol 2005; 12:459-466 (Pubitemid 40884260)
32. Elias D, Cavalcanti de Albuquerque A, Eggenspieler P, Plaud B, Ducreux M, Spielmann M. Resection of liver metastases from a noncolorectal primary: Indications and results based on 147 monocentric patients. J Am Coll Surg 1998; 187:487-493 (Pubitemid 28506854)
33. Lendoire J, Moro M, Andriani O, Grondona J, Gil O, Raffin G, et al. Liver resection for non-colorectal, non-neuroendocrine metastases: Analysis of a multicenter study from Argentina. HPB (Oxford) 2007; 9:435-439 (Pubitemid 350215038)
34. Lang H, Nussbaum KT, Weimann A, Raab R. Liver resection for noncolorectal, non-neuroendocrine hepatic metastases. Chirurg 1999; 70:439-446
35. Yedibela S, Gohl J, Graz V, Pfaffenberger MK, Merkel S, Hohenberger W, et al. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: A single-institutional review. Ann Surg Oncol 2005; 12:778-785 (Pubitemid 41355929)
36. Herman P, Machado MA, Montagnini AL, D'Albuquerque LA, Saad WA, Machado MC. Selected patients with metastatic melanoma may benefit from liver resection. World J Surg 2007; 31:171-174 (Pubitemid 46089562)
37. Reddy SK, Barbas AS, Marroquin CE, Morse MA, Kuo PC, Clary BM. Resection of noncolorectal nonneuroendocrine liver metastases: A comparative analysis. J Am Coll Surg 2007; 204:372-382 (Pubitemid 46283502)
38. Aoyama T, Mastrangelo MJ, Berd D, Nathan FE, Shields CL, Shields JA. Protracted survival after resection of metastatic uveal melanoma. Cancer 2000; 89:1561-1568
39. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318, discussion 318-321
40. Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 2010; 363:809-819
41. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364:2507-2516
42. Luke JJ, Hodi FS. Vemurafenib and BRAF inhibition: A new class of treatment for metastatic melanoma. Clin Cancer Res 2012; 18:9-14
43. Van Etten B, de Wilt JH, Brunstein F, Eggermont AM, Verhoef C. Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases. Eur J Surg Oncol 2009; 35:539-545
44. Van Iersel LB, Hoekman EJ, Gelderblom H, Vahrmeijer AL, van Persijn van Meerten EL, et al. Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases. Ann Surg Oncol 2008; 15:1891-1898
45. Varghese S, Xu H, Bartlett D, Hughes M, Pingpank JF, Beresnev T, et al. Isolated hepatic perfusion with high-dose melphalan results in immediate alterations in tumor gene expression in patients with metastatic ocular melanoma. Ann Surg Oncol 2010; 17:1870-1877
46. De Wilt J.H, Eggermont A.M., When To Perform Surgery In Stage IV Melanoma Patients? Onkologie 2008 31 226-227. (Pubitemid 351744821)